Parameters (pg/mL) | Sedentary groups with different infection status | *p | |||
---|---|---|---|---|---|
Sedentary and Infected group | Sedentary and Un-infected | Non-sedentary and Infected group | Non-sedentary and Un-infected group | ||
Pro-inflammatory cytokines | Median (IQR), n | ||||
TNF-α | 12.95 (10.03–15.59) 13 | 10.72 (8.55–12.89) 7 | 9.84 (6.45–11.92) 9 | 12.69 (7.93–14.51) 4 | 0.349 |
IL-1β | 3.35 (2.91–4.67) 10 | 3.91 (1.98–9.58) 5 | 3.14 (2.36–4.59) 6 | 4.56 (3.62–5.44) 4 | 0.615 |
IL-6 | 37.63 (26.48–50.68) 13 | 33.21 (25.49–47.9) 8 | 27.78 (20.98–36.3) 9 | 42.01 (21.21–56.59) 3 | 0.534 |
IFN-γ | 6.89 (3.83–10.18) 17 | 6.00 (3.86–7.47) 8 | 6.25 (3.87–8.81) 12 | 5.52 (2.16–9.92) 4 | 0.867 |
IL-8 | 13.6 (10.25–19.34) 8 | 47.38 (7.60–395.00) 5 | 15.93 (7.36–22.12) 5 | 35.95 (5.36–404.4) 4 | 0.685 |
IL-12 | 4.68 (3.78–5.83) 12 | 4.12 (2.75–5. 86) 7 | 4.27 (3.87–5.96) 7 | 1.99 (1.80–3.54) 4 | 0.119 |
Anti-inflammatory cytokines | Median (IQR), n | ||||
IL-10 | 34.4 (23.94–69.84) 13 | 12.66 (11.82–35.28) 5 | 16.49 (14.39–27.41) 7 | 17.37 (11.53–29.71) 4 | 0.098 |
IL-7 | 20.22 (17.72–26.28) 7 | 17.04 (11.92–20.51) 8 | 19.24 (10.46–19.76) 3 | 17.81 (10.53–34.92) 4 | 0.461 |
IL-13 | 30.14 (25.00–36.64) 10 | 19.65 (15.86–48.81) 5 | 27.47 (14.63–38.20) 9 | 23.26 (15.70–34.90) 4 | 0.852 |